Affidea

Affidea is benefiting from a large, growing and resilient market, driven by solid fundamentals:

• Tailwinds including an ageing population and increasing focus on preventive medicine
• Resilience through economic cycles, given the critical nature of the services and market undersupply
• Exposure to countries growing above the European average of + 4% per annum
• Economies of scale from: (i) sticky long-term contracts with the public sector, (ii) high capital requirements, (iii) complex regulations and licenses requirements and (iv) radiologist shortages

In addition, the fragmented European market offers M&A opportunities in existing and new countries.

Affidea is well positioned to win:

• Diversification across geographies, payors (e.g., public and private), services and regulations
• Over-indexed to higher-growth complex modalities
• Strong financial profile, with consistent organic growth and solid M&A track record
• Margin improvement potential, e.g., from sharing best practice and improving medical productivity by reducing doctors’ administrative burden
• Artificial intelligence to provide additional opportunities in teleradiology

Affidea has a reputation for clinical excellence, with a core focus on providing quality care:

• Europe’s most awarded diagnostic imaging provider
• Partner of choice for doctors, patients and payors
• Focus on developing new technologies with OEMs

Over the past year, the Board and management have been strengthened with additional high-caliber appointments.